AbbVie Inc. Depreciation & Amortization 2011-2026 | ABBV
Beta
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is AbbVie Inc.'s current depreciation & amortization?
AbbVie Inc. (ABBV) annual depreciation & amortization for 2025 was $762.0M, a 0.26% decline from 2024. AbbVie Inc. depreciation & amortization for the quarter ending March 31, 2026 was $188.0M.
What was AbbVie Inc.'s depreciation & amortization in 2024?
AbbVie Inc. annual depreciation & amortization for 2024 was $764.0M, a 1.60% increase from 2023.
What was AbbVie Inc.'s depreciation & amortization in 2023?
AbbVie Inc. annual depreciation & amortization for 2023 was $752.0M, a 3.34% decline from 2022.
What is AbbVie Inc.'s 5-year depreciation & amortization CAGR?
AbbVie Inc. depreciation & amortization grew at a compound annual growth rate (CAGR) of 2.73% from FY2020 to FY2025, going from $666.0M to $762.0M over 5 years.
Depreciation & Amortization History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.7%
FY2020
$666.0M
→
FY2025
$762.0M
111213141516171819202122232425
5 years selected
Depreciation & Amortization History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $762.0M | -0.3% | 10-K |
| FY2024 | $764.0M | +1.6% | 10-K |
| FY2023 | $752.0M | -3.3% | 10-K |
| FY2022 | $778.0M | -3.1% | 10-K |
| FY2021 | $803.0M | +20.6% | 10-K |
| FY2020 | $666.0M | +43.5% | 10-K |
| FY2019 | $464.0M | -1.5% | 10-K |
| FY2018 | $471.0M | +10.8% | 10-K |
| FY2017 | $425.0M | +0.0% | 10-K |
| FY2016 | $425.0M | +1.9% | 10-K |
| FY2015 | $417.0M | +8.9% | 10-K |
| FY2014 | $383.0M | -1.3% | 10-K |
| FY2013 | $388.0M | -26.1% | 10-K |
| FY2012 | $525.0M | +3.3% | 10-K |
| FY2011 | $508.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →